49 related articles for article (PubMed ID: 38438666)
1. RUNX1 regulates MCM2/CDC20 to promote COAD progression modified by deubiquitination of USP31.
Tian W; Zhao J; Zhang X; Li P; Li X; Hong Y; Li S
Sci Rep; 2024 Jun; 14(1):13906. PubMed ID: 38886545
[TBL] [Abstract][Full Text] [Related]
2. Antitumor Effect of Apcin on Endometrial Carcinoma via p21-Mediated Cell Cycle Arrest and Apoptosis.
Ni K; Li ZL; Hu ZY; Hong L
Curr Med Sci; 2024 Jun; ():. PubMed ID: 38853192
[TBL] [Abstract][Full Text] [Related]
3. Expression, Prognostic Value, and Immune Infiltration of MTHFD Family in Bladder Cancer.
Zheng BS; Wang S; Zhang JY; Ge CG
Curr Cancer Drug Targets; 2024; 24(2):178-191. PubMed ID: 37539926
[TBL] [Abstract][Full Text] [Related]
4. The predictive significance of CDC20 across various molecular subtypes of breast cancer.
Li Q; Wang W
Asian J Surg; 2024 Jun; ():. PubMed ID: 38853113
[No Abstract] [Full Text] [Related]
5. CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies.
Bruno S; Ghelli Luserna di Rorà A; Napolitano R; Soverini S; Martinelli G; Simonetti G
J Exp Clin Cancer Res; 2022 Apr; 41(1):159. PubMed ID: 35490245
[TBL] [Abstract][Full Text] [Related]
6. The potential role of CDC20 in tumorigenesis, cancer progression and therapy: A narrative review.
Xian F; Zhao C; Huang C; Bie J; Xu G
Medicine (Baltimore); 2023 Sep; 102(36):e35038. PubMed ID: 37682144
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics analysis and experimental validation reveal that CDC20 overexpression promotes bladder cancer progression and potential underlying mechanisms.
Liu Y; Zou SH; Gao X
Genes Genomics; 2024 Apr; 46(4):437-449. PubMed ID: 38438666
[TBL] [Abstract][Full Text] [Related]
8. Identification of cell division cycle 20 as a candidate biomarker and potential therapeutic target in bladder cancer using bioinformatics analysis.
Shen P; He X; Lan L; Hong Y; Lin M
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677673
[TBL] [Abstract][Full Text] [Related]
9. CDC20 promotes radioresistance of prostate cancer by activating Twist1 expression.
Yang C; Ge Y; Zang Y; Xu M; Jin L; Wang Y; Xu X; Xue B; Wang Z; Wang L
Apoptosis; 2023 Dec; 28(11-12):1584-1595. PubMed ID: 37535214
[TBL] [Abstract][Full Text] [Related]
10. MYBL2 in synergy with CDC20 promotes the proliferation and inhibits apoptosis of gastric cancer cells.
Deng Q; Wu L; Li Y; Zou L
Adv Clin Exp Med; 2021 Sep; 30(9):957-966. PubMed ID: 34358419
[TBL] [Abstract][Full Text] [Related]
11. High expression of spindle assembly checkpoint proteins CDC20 and MAD2 is associated with poor prognosis in urothelial bladder cancer.
Choi JW; Kim Y; Lee JH; Kim YS
Virchows Arch; 2013 Nov; 463(5):681-7. PubMed ID: 23995871
[TBL] [Abstract][Full Text] [Related]
12. REC8 inhibits proliferation, migration and invasion of breast cancer cells by targeting CDC20.
He S; Liu D; Chen Z
Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35616161
[TBL] [Abstract][Full Text] [Related]
13. CCT6A is associated with CDC20, Enneking stage and prognosis in osteosarcoma, and its knockdown suppresses osteosarcoma cell viability and invasion.
Wang N; Chen Y; Wu J
Oncol Lett; 2023 May; 25(5):201. PubMed ID: 37113398
[TBL] [Abstract][Full Text] [Related]
14. STIL/AURKA axis promotes cell proliferation by influencing primary cilia formation in bladder cancer.
Li J; Qi Y; Li B; Liu Y; Yang K; Zhang Z; Zhu J; Du E
J Transl Med; 2023 Apr; 21(1):281. PubMed ID: 37101292
[TBL] [Abstract][Full Text] [Related]
15. CDC20: a novel therapeutic target in cancer.
He W; Meng J
Am J Transl Res; 2023; 15(2):678-693. PubMed ID: 36915766
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
